The Cellular Pharmacology of F-TAF in Dried Blood Spots
NCT02962739
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
emtricitabine 200 mg/tenofovir alafenamide 25mg
Sponsor
University of Colorado, Denver